GS TFC Pill - yellow oval
Generic Name: trametinib
Pill with imprint GS TFC is Yellow, Oval and has been identified as Mekinist 0.5 mg. It is supplied by GlaxoSmithKline.
Mekinist is used in the treatment of Melanoma, Metastatic; Solid Tumors; Thyroid Cancer; Low-Grade Glioma; Non-Small Cell Lung Cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Mekinist 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GS TFC
Mekinist
- Generic Name
- trametinib
- Imprint
- GS TFC
- Strength
- 0.5 mg
- Color
- Yellow
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
hypromelloses,
croscarmellose sodium,
magnesium stearate,
sodium lauryl sulfate,
silicon dioxide,
titanium dioxide,
polyethylene glycol,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00173-0849 (Discontinued) | GlaxoSmithKline |
| 00078-0666 | Novartis Pharmaceuticals Corporation |
More about Mekinist (trametinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
